CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Norbert Scherbaum

OPENALEX: A5026643169↗ORCID: 0000-0003-1759-6990↗

Affiliations

Organizations

Essen University Hospitalauthorship · DE Kliniken Essen-Mitteauthorship · DE University of Duisburg-Essenauthorship · DE

Public evidence

8 connected articles

Attitudes of Patients with Non-Psychotic Mental Disorders Towards Cannabis After Its Legalization-Comparison with Patients Before Legalization.2026 · PubMed Central Open Access Health-Related Quality of Life in Previous Versus Current Opiate Users Receiving HCV Therapy: Registry-Based Evidence.2026 · Europe PMC Drugs Used in "Chemsex"/Sexualized Drug Behaviour-Overview of the Related Clinical Psychopharmacological Issues.2025 · Europe PMC Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review.2022 · PubMed Central Open Access Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials.2022 · Europe PMC Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.2020 · PubMed Central Open Access Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?2020 · Europe PMC Alterations of Monetary Reward and Punishment Processing in Chronic Cannabis Users: An fMRI Study2015 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Norbert Scherbaum - Medical Cannabis Research Engine